FDA Issues Important Guidance Documents On Drug Risk Management Plans And Out-of-Specification Test Results - Healthcare
In May 2022, the US Food and Drug Administration (FDA), released two important guidance documents: Risk Management Plans to Mitigate the Potential for Drug Shortages Guidance for Industry...
Source: mondaq.com